Compare Amylx Pharmaceuticals Inc (AMLX) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Amylx Pharmaceuticals Inc vs Southern Copper Corp — how do they compare? Amylx Pharmaceuticals Inc trades at $23.96 (market cap $2.64B), while Southern Copper Corp trades at $197.1 (market cap $164.21B). The key difference: Southern Copper Corp is far larger — about 62.2× Amylx Pharmaceuticals Inc's market cap, and Southern Copper Corp pays a 2.26% dividend while Amylx Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| AMLX | SCCO | |
|---|---|---|
Market Cap | $2.64B | $164.21B |
Sector | Health | Basic Materials |
52-Week High | $24.19 | $218.85 |
52-Week Low | $7.82 | $93.70 |
Enterprise Value | $2.39B | $165.50B |
Dividend Yield | — | 2.26% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Amylx Pharmaceuticals Inc
Amylyx Pharmaceuticals is a biopharmaceutical firm focused on developing therapies for rare diseases. Its pipeline includes treatments for conditions like post-bariatric hypoglycemia and congenital hyperinsulinism.
Read more on AMLX →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
